The impact of changing the reference countries on the list prices for patented medicines in Canada: A policy analysis.
- DOI
- 10.1016/j.healthpol.2024.105064
- Published
- 2024 Jun
- Container
- Health policy (Amsterdam, Netherlands)
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.healthpol.2024.105064,
title = {The impact of changing the reference countries on the list prices for patented medicines in Canada: A policy analysis.},
author = {Zhang W and Guh DP and Grootendorst P and Hollis A and Anis AH},
year = {2024},
journal = {Health policy (Amsterdam, Netherlands)},
doi = {10.1016/j.healthpol.2024.105064},
url = {https://doi.org/10.1016/j.healthpol.2024.105064}
}RIS
TY - JOUR TI - The impact of changing the reference countries on the list prices for patented medicines in Canada: A policy analysis. AU - Zhang W AU - Guh DP AU - Grootendorst P AU - Hollis A AU - Anis AH PY - 2024 JO - Health policy (Amsterdam, Netherlands) DO - 10.1016/j.healthpol.2024.105064 UR - https://doi.org/10.1016/j.healthpol.2024.105064 ER -
APA
W, Z., DP, G., P, G., A, H., & AH, A. (2024). The impact of changing the reference countries on the list prices for patented medicines in Canada: A policy analysis.. Health policy (Amsterdam, Netherlands). https://doi.org/10.1016/j.healthpol.2024.105064
Source records
- pubmed · retrieved 2026-09-26T07:29:42.367Z